Association between CD8+ tumor-infiltrating lymphocytes and prognosis of non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitors: a systematic review and meta-analysis.
Qi-Ming ZhengYuan-Yuan LiYe-Peng WangGuo-Xiang LiMeng-Meng ZhaoZhi-Gang SunPublished in: Expert review of anticancer therapy (2023)
In spite of the location of CD8+ TILs, high densities of CD8+ TILs were predictive of treatment outcomes in NSCLC patients treated with PD-1/PD-L1 inhibitors. However, high CD8+ TILs in peripheral blood had no predictive effect.